期刊文献+

高能X线照射对肿瘤细胞表达MICA及NK细胞功能的影响 被引量:1

Influence of MICA expression on tumor cell lines and cytotoxicity of NK cells by irradiation
下载PDF
导出
摘要 目的探讨肿瘤细胞接受不同剂量高能X线照射后,细胞表面MICA抗原表达及对NK细胞功能的影响。方法分别取T淋巴细胞株T2、结肠腺癌细胞株LS-174-T及食管鳞癌细胞株ECA-109,经0、4、8、163、2 Gy的剂量照射,16 h过夜培养,给细胞标记MICA的单克隆抗体,分析肿瘤细胞平均荧光密度(MFI的变化。并将外周血单个核细胞与经优化剂量照射的肿瘤细胞按10∶1比例孵育,4 h后利用流式细胞术胞内染色法分析NK细胞释放穿孔素的情况以评价NK细胞的杀伤毒性。结果不同肿瘤细胞株上调MICA表达的最佳放疗剂量不同,而肿瘤细胞上调MICA表达后可增强NK细胞的杀伤毒性。结论适宜的放射剂量促进肿瘤细胞表达MICA抗原而增强机体免疫功能。 Objective To investigate the effects of MICA expression on different tumor cell lines by a variety of doses of irradiation and the corresponding activation of NK cells. Methods Three cell lines, T2 (T cell lymphoma), LS-174-T (colon cancer), ECA-109 (esophageal squamous cell cancer), were all irradiated with the increased doses of 0, 4, 8, 16, 32 Gy..Ajter overnight cultivation, those cells were labeled with MICA monoclonal antibody and detected the mean fluorescence intensity (MFI) on tumor cells by flow cytometry. In addition, the peripheral blood mononuclear cells were mixed with the optimal irradiated tumor cells with a ratio of 10 : 1. Four hours later, perforin positive NK cells were analyzed by intracellular staining with anti-CD56 and anti-perforin monoclonal antibodies. The percentage of NK cells with secretion of perforin were calculated and regarded as a parameter of cytotoxicity. Results The up-regulated MICA expression on different cell lines needed the different doses of irradiation. The increased expression of MICA on cell membrane could enhance the cytotoxicity of NK cells. Conclusions The optimal dose of irradiation could strengthen the immune surveillance via up - regulating MICA expression on tumor cells.
出处 《实用临床医药杂志》 CAS 2009年第5期21-23,36,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助项目(30671917) 江苏省自然科学基金资助项目(BK2004404 BK2008215) 江苏省高校自然科学基金资助项目(04KJB320162)
关键词 放疗 肿瘤 MICA NK细胞 irradiation tumor MICA NK cell
  • 相关文献

参考文献11

  • 1龚卫娟.MICA基因研究进展[J].国外医学(遗传学分册),2001,24(4):184-188. 被引量:14
  • 2Gasser S, Raulet D H. The DNA Damage Response Arouses the Immune System[J]. Cancer Res, 2006, 66(8): 3959.
  • 3González S, Lopez-Soto A, Suarez-Alvarez B, et al. NKG2D ligands: key targets of the immune response[J]. Trends Immunol, 2008, 29(8): 397.
  • 4Gasser S, Orsulic S, Brown E J, et al. The DNA damage pathway regulates innate immune system ligands for the NKG2D receptor[J]. Nature, 2005, 436(7054): 1186.
  • 5Gasser S, Raulet D H. The DNA damage response, immunity and cancer[J]. 2006, Semin Cancer Biol, 16(5): 344.
  • 6Ehrke M J, Mihich E. Immunomodulation in cancer therapeutics[J]. Int Immunopharmacol, 2003, 3(8): 1105.
  • 7Zagozdzon R, Golab J. Immunomodulation by anticancer chemotherapy: more is not always better [J]. Int J Oncol, 2001, 18 (2): 417.
  • 8DiPaola R S, Durivage H J, Kamen B A. High time for low-dose prospective clinical trials[J]. Cancer, 2003, 98(8): 1559.
  • 9Groh V, Wu J, Yee C, et al. Tumor-derived soluble MIC ligands impair expression of NKG2D and T-cell activation [J]. Nature, 2002, 419 (9): 734.
  • 10Jinushi M, Hodi F S, Dranoff G. Therapies-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity [J]. PNAS, 2006, 103 (6): 9190.

二级参考文献1

  • 1郭忠慧.-[J].中华风湿病学杂志,1999,3:4-7.

共引文献13

同被引文献13

  • 1Salih HR, Antropius H, Gieseke F, et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia [J]. Blood, 2005, 102(4) : 1389 -1396.
  • 2Jinushi M, Hodl FS, Dranoff G. Therapies - induced antibodies to MHC class Ⅰ chain - related protein A antagonize immune suppression and stimulate antitumor cytotoxicity [ J]. PNAS, 2006, 103 (6) : 9190 -9195.
  • 3Oppenheim DE, Roberts SJ, Clarke SL, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance [J]. Nat Immunol, 2004, 6(9): 928-937.
  • 4Gasser S, Raulet DH. The DNA damage response arouses the immune system [J]. Cancer Res, 2006, 66 (8) : 3959 -3962.
  • 5Groh V, Wu J, Yee C, et al. Tumor - derived soluble MIC li - gands impair expression of NKG2D and T - cell activation [J]. Nature, 2002, 419 (9) : 734 -738.
  • 6Wu JD, Higgins LM, Steinle A, et al. Prevalent expression of the immunostimulatory MHC class Ⅰ chain - related molecule is counteracted by shedding in prostate cancer [ J]. J Clin Invest, 2004, 114(4) : 560-568.
  • 7Doubrovina ES, Doubrovin MM, Vider E, et al. Evasion from NK cell immunity by MHC class Ⅰ chain - related molecules expressing colon adenocarcinoma. [ J ]. J Immunol, 2003, 171 (12) : 6891 - 6899.
  • 8Jumnainsong A, Romphruk AV, Jearanaikoon P, et al. Association of polymorphic extracellular domains of MICA with cervical cancer in northeastern Thai population [ J ]. Tissue Antigens, 2007, 69(4) : 326- 333.
  • 9Tamaki S, Sanefuzi N, Kawakami M, et al. Association between soluble MICA levels and disease stage Ⅳ oral squamous cell carcinoma in Japanese patients [J]. Hum Immonol, 2008, 69(2) :88 -93.
  • 10Gonzalez S, Lopez- Soto A, Suarez- Alvarez B, et al. NKG2D ligands: key targets of the immune response [ J]. Trends Immunol, 2008, 29 (8) : 397 -403.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部